Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

Jihye Park, Jae Hee Cheon

Research output: Contribution to journalEditorial

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)263-265
Number of pages3
JournalIntestinal Research
Volume15
Issue number3
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Intestinal Diseases
Behcet Syndrome
Therapeutics
Adalimumab

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

@article{6ff5ef75dbac45a8b1456f3022535038,
title = "Could adalimumab be used safely and effectively in intestinal Beh{\cc}et's disease refractory to conventional therapy?",
author = "Jihye Park and Cheon, {Jae Hee}",
year = "2017",
month = "1",
day = "1",
doi = "10.5217/ir.2017.15.3.263",
language = "English",
volume = "15",
pages = "263--265",
journal = "Intestinal Research",
issn = "1598-9100",
publisher = "Korean Association for the Study of Intestinal Diseases",
number = "3",

}

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? / Park, Jihye; Cheon, Jae Hee.

In: Intestinal Research, Vol. 15, No. 3, 01.01.2017, p. 263-265.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

AU - Park, Jihye

AU - Cheon, Jae Hee

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85020459822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020459822&partnerID=8YFLogxK

U2 - 10.5217/ir.2017.15.3.263

DO - 10.5217/ir.2017.15.3.263

M3 - Editorial

AN - SCOPUS:85020459822

VL - 15

SP - 263

EP - 265

JO - Intestinal Research

JF - Intestinal Research

SN - 1598-9100

IS - 3

ER -